Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults

Clinical trial NCT02669121 · COMPLETED

Trial details

NCT number: NCT02669121
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2016-06-14
Primary completion: 2018-06-16
Enrollment: 4748

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.